Moderna takes hit in mRNA battles; Sisvel launches IoT patent pool; Nokia bags UK win in Oppo spat; WiLAN Q3 revenues; part-time UPC judges trigger concerns; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

The Long Read

Here’s how to get attorney fee awards in US patent litigation. Read more here

MONDAY 07 November

Good news for owners – and would-be owners – of broad, functionally-defined pharmaceutical patents as SCOTUS agreed to review the Patent Act enablement standard. Read more here

Farewell, it seems, to Fintiv discretionary denials as Docket Navigator data shows the drastic impact that USPTO Director Kathi Vidal’s new discretionary denial policies have had. Read more here

TUESDAY 08 November

Moderna Therapeutics’ attempts to thwart a number of high-stakes mRNA vaccine patent infringement suits against it took a hit. Read more here

The lower cost of design patents enables IP holders to file quickly and often, gaining early exclusionary rights to block competitors and protect market share. Read more here

USPTO Director Kathi Vidal rejected a request by VLSI Technology to reconsider her director review ruling which placed Intel Corp as the lead petitioner in an inter partes review. Read more here

WEDNESDAY 09 November

Sisvel launched its Cellular IoT Patent Pool which will offer a licence to SEPs for two low-power wide-area network standards: LTE-M and Narrowband IoT. Read more here

IBM patent search tool is latest example of USPTO 'venture capital' approach. Read more here

THURSDAY 10 November

Vivo Surgical’s founder spoke to IAM about building an award-winning medtech offering via a strong IP and IA portfolio. Read more here

Nokia bags another UK victory over Oppo, adding to string of European wins. Read more here

WiLAN’s Q3 revenues plummet in comparison to 2021 but Micron deal excluded from reporting. Read more here

FRIDAY 11 November

Auto SEP owners could see licensing fees shrink in China if new guidelines are enforced. Read more here

While final outcomes of the US midterms are still pending, the outlook IP policy will remain high on the agenda. Read more here

Industry leaders shared their wisdom during IAM’s Patent Transactions event. Read more here

SATURDAY 12 November

As the advent of the United Patent Court looms, decisive and transparent action must be taken to address concerns about conflict of interest risks arising from part-time judges. Read more here